Cubist Systematic Strategies’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,754
Closed -$150K 4521
2022
Q4
$150K Sell
14,754
-5,246
-26% -$53.1K ﹤0.01% 3693
2022
Q3
$200K Buy
+20,000
New +$200K ﹤0.01% 3766

Other funds holding SBC

Cubist Systematic Strategies's SBC Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of SBC Medical Group (SBC) in Q1 2023, closing a stake of 14,754 shares — an estimated $150K sold.

Cubist Systematic Strategies first reported a position in SBC in Q3 2022 and held it in 2 quarters. The position peaked at $200K in Q3 2022. 38 funds tracked by Wall St. Rank hold SBC as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining SBC Medical Group position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 14,754 SBC Medical Group shares in Q1 2023, an estimated $150K.
  • Cubist Systematic Strategies first reported a position in SBC Medical Group in Q3 2022 and held it in 2 quarters.
  • Cubist Systematic Strategies's SBC Medical Group position peaked at $200K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.